Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Multiple Myeloma Care in the Community Setting by Utilizing Progressive Clinical Care Pathways

Vikram Dhillon, MD, Danko Martincic, MD, Christopher M Lee, MD, Ndegwa Njuguna, MD, David Schmick, RPh, Annette K Nagle, RN, BSN, Rachel L Garman, CCRC, Hakan Kaya, MD

Blood (2012) 120 (21): 5053.

https://doi.org/10.1182/blood.V120.21.5053.5053

Published: 2012

Journal Articles

Rapid Clearance of Rituximab Contributes to the Continued High Incidence of Autoimmune Complications of Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Clifton C. Mo, MD, Mohammed Z.H. Farooqui, DO, Paul V. Beum, PhD, Ndegwa Njuguna, MD, Gerald E Marti, MD, PhD, Wyndham H. Wilson, MD, PhD, Ronald P. Taylor, PhD, Adrian U. Wiestner, MD, PhD

Blood (2010) 116 (21): 4628.

https://doi.org/10.1182/blood.V116.21.4628.4628

Published: 2010

Journal Articles

Comparative Gene Expression Profiling of Leukemia Cells in Peripheral Blood and Tissue Compartments Reveals a Prominent Role of the Microenvironment for CLL Cell Proliferation.

Yair Herishanu, MD, Patricia Perez-Gelen, PhD, Delong Liu, PhD, Angelique Biancotto, PhD, Berengere Vire, PhD, Federica Gibellini, PhD, Ndegwa Njuguna, MD, Philip McCoy, PHD, Stefania Pittaluga, MD, Maryalice Stettler-Stevenson, Peter J Munson, PhD, Wyndham H Wilson, MD, PhD, Adrian Wiestner, MD, PhD

Blood (2009) 114 (22): 355.

https://doi.org/10.1182/blood.V114.22.355.355

Published: 2009

Journal Articles

CD44 Signaling Via PI3K/AKT and MAPK/ERK Pathways Protects CLL Cells from Spontaneous and Drug Induced Apoptosis

Yair Herishanu, MD, Federica Gibellini, PhD, Ndegwa Njuguna, MD, Keyvan Keyvanfar, BS, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 541.

https://doi.org/10.1182/blood.V112.11.541.541

Published: 2008

Journal Articles

High Incidence of Autoimmune Complications during Combined Fludarabine and Rituximab Therapy in CLL: Rapid Clearance of Rituximab as a Contributing Factor

Ndegwa Njuguna, MD, Paul V Beum, PhD, Berengere Vire, PhD, Gerald E Marti, MD, PhD, Therese White, RN, Wyndham H. Wilson, MD, PhD, Ronald P Taylor, PhD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 4208.

https://doi.org/10.1182/blood.V112.11.4208.4208

Published: 2008

Journal Articles

Lenalidomide Induced Cytokine Release Syndrome in Chronic Lymphocytic Leukemia (CLL): Clinical and Laboratory Correlates of Immune Activation.

Georg Aue, MD, Ndegwa Njuguna, MD, Xin Tian, PhD, Janet Valdez, PA, Susan Soto, RN, J. Philip McCoy, Jr., PhD, Leigh Samsel, Berengere Vire, PhD, Keyvan Keyvanfar, Stefania Pittaluga, MD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 2099.

https://doi.org/10.1182/blood.V112.11.2099.2099

Published: 2008

Journal Articles

Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) Is Expressed in Low Grade NHL and B-CLL and Activates the Non Canonical Wnt Pathway

Federica Gibellini, PhD, Colby M Chapman, BS, Yair Herishanu, MD, Berengere Vire, PhD, Keyvan Keyvanfar, Ndegwa Njuguna, MD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 3748.

https://doi.org/10.1182/blood.V112.11.3748.3748

Published: 2008

Journal Articles

The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF κB as Dominant Signaling Pathways

Yair Herishanu, MD, Berengere Vire, PhD, Delong Liu, PhD, Federica Gibellini, PhD, Gerald E Marti, MD, PhD, Therese White, RN, Ndegwa Njuguna, MD, Nalini Raghavachari, PhD, Poching Liu, PhD, Stefania Pittaluga, MD, PhD, Peter J Munson, PhD, Wyndham H. Wilson, MD, PhD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 356.

https://doi.org/10.1182/blood.V112.11.356.356

Published: 2008

Journal Articles

Molecular Effects of Rituximab on CLL Cells In Vivo : Rapid Increase in Serum Interferon gamma, Induction of a Distinct Tumor Cell Gene Expression Signature and Loss of CD20 Expression.

Adrian Wiestner, MD, PhD, Elinor Lee, BA, Berengere Vire, PhD, Federica Gibellini, PhD, Ndegwa Njuguna, MD, Yair Herishanu, MD, Delong Liu, PhD, Peter Munson, PhD, Nalini Raghavachari, PhD, Therese White, RN, Gerald E. Marti, MD, PhD, Wyndham H. Wilson, MD, PhD

Blood (2007) 110 (11): 2048.

https://doi.org/10.1182/blood.V110.11.2048.2048

Published: 2007

NARROW

Multiple Myeloma Care in the Community Setting by Utilizing Progressive Clinical Care Pathways

Rapid Clearance of Rituximab Contributes to the Continued High Incidence of Autoimmune Complications of Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Comparative Gene Expression Profiling of Leukemia Cells in Peripheral Blood and Tissue Compartments Reveals a Prominent Role of the Microenvironment for CLL Cell Proliferation.

CD44 Signaling Via PI3K/AKT and MAPK/ERK Pathways Protects CLL Cells from Spontaneous and Drug Induced Apoptosis

High Incidence of Autoimmune Complications during Combined Fludarabine and Rituximab Therapy in CLL: Rapid Clearance of Rituximab as a Contributing Factor

Lenalidomide Induced Cytokine Release Syndrome in Chronic Lymphocytic Leukemia (CLL): Clinical and Laboratory Correlates of Immune Activation.

Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) Is Expressed in Low Grade NHL and B-CLL and Activates the Non Canonical Wnt Pathway

The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF κB as Dominant Signaling Pathways

Molecular Effects of Rituximab on CLL Cells In Vivo : Rapid Increase in Serum Interferon gamma, Induction of a Distinct Tumor Cell Gene Expression Signature and Loss of CD20 Expression.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only